This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, J. J.
Right arrow Articles by Gaffen, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J. J.
Right arrow Articles by Gaffen, S. L.

 Previous Article  |  Next Article 

Infection and Immunity, September 2008, p. 4206-4213, Vol. 76, No. 9
0019-9567/08/$08.00+0     doi:10.1128/IAI.01209-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The Interleukin-17 Receptor Plays a Gender-Dependent Role in Host Protection against Porphyromonas gingivalis-Induced Periodontal Bone Loss{triangledown}

Jeffrey J. Yu,1 Matthew J. Ruddy,1 Heather R. Conti,2 Kanitsak Boonanantanasarn,2 and Sarah L. Gaffen1,2*

Department of Microbiology and Immunology,1 Department of Oral Biology, University at Buffalo, SUNY, Buffalo, New York2

Received 3 September 2007/ Returned for modification 10 October 2007/ Accepted 18 June 2008

Interleukin-17 (IL-17) is a proinflammatory cytokine secreted by the newly described CD4+ Th17 subset, which is distinct from classic Th1 and Th2 lineages. IL-17 contributes to bone destruction in rheumatoid arthritis but is essential in host defense against pathogens that are susceptible to neutrophils. Periodontal disease (PD) is a chronic inflammatory condition initiated by anaerobic oral pathogens such as Porphyromonas gingivalis, and it is characterized by host-mediated alveolar bone destruction due primarily to the immune response. The role of IL-17 in PD is controversial. Whereas elevated IL-17 levels have been found in humans with severe PD, we recently reported that female C57BL/6J mice lacking the IL-17 receptor (IL-17RAKO) are significantly more susceptible to PD bone loss due to defects in the chemokine-neutrophil axis (J. J. Yu, M. J. Ruddy, G. C. Wong, C. Sfintescu, P. J. Baker, J. B. Smith, R. T. Evans, and S. L. Gaffen, Blood 109:3794-3802, 2007). Since different mouse strains exhibit differences in susceptibility to PD as well as Th1/Th2 cell skewing, we crossed the IL-17RA gene knockout onto the BALB/c background and observed a similar enhancement in alveolar bone loss following P. gingivalis infection. Unexpectedly, in both strains IL-17RAKO female mice were much more susceptible to PD bone loss than males. Moreover, female BALB/c-IL-17RAKO mice were defective in producing anti-P. gingivalis immunoglobulin G and the chemokines KC/Gro{alpha} and MIP-2. In contrast, male mice produced normal levels of chemokines and anti-P. gingivalis antibodies, but they were defective in granulocyte colony-stimulating factor upregulation. This study demonstrates a gender-dependent effect of IL-17 signaling and indicates that gender differences should be taken into account in the preclinical and clinical safety testing of anti-IL-17 biologic therapies.


* Corresponding author. Present address: University of Pittsburgh, Division of Rheumatology and Clinical Immunology, S708 Biomedical Science Tower, 3500 Terrace St., Pittsburgh, PA 15261. Phone: (412) 383-8903. Fax: (412) 383-8864. E-mail: sig65{at}pitt.edu

{triangledown} Published ahead of print on 30 June 2008.

Editor: J. L. Flynn


Infection and Immunity, September 2008, p. 4206-4213, Vol. 76, No. 9
0019-9567/08/$08.00+0     doi:10.1128/IAI.01209-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Algood, H. M. S., Allen, S. S., Washington, M. K., Peek, R. M. Jr., Miller, G. G., Cover, T. L. (2009). Regulation of Gastric B Cell Recruitment Is Dependent on IL-17 Receptor A Signaling in a Model of Chronic Bacterial Infection. J. Immunol. 183: 5837-5846 [Abstract] [Full Text]  
  • Crowe, C. R., Chen, K., Pociask, D. A., Alcorn, J. F., Krivich, C., Enelow, R. I., Ross, T. M., Witztum, J. L., Kolls, J. K. (2009). Critical Role of IL-17RA in Immunopathology of Influenza Infection. J. Immunol. 183: 5301-5310 [Abstract] [Full Text]  
  • Vojdani, A., Lambert, J., Kellermann, G. (2009). The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III. Evid Based Complement Alternat Med 0: nep064v1-nep064 [Abstract] [Full Text]  
  • Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., Filler, S. G., Masso-Welch, P., Edgerton, M., Gaffen, S. L. (2009). Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. JEM 206: 299-311 [Abstract] [Full Text]